Abstract
Oral antibiotics are a mainstay in the treatment of moderate to severe inflammatory acne vulgaris. Widespread and prolonged use of oral antibiotics contributes to antibiotic resistance, which has negative public health implications. This retrospective cohort study, conducted from January 2014 through September 2016 using the IBM® MarketScan® claims database, evaluated trends in oral antibiotic use for acne treatment. Patients were ≥9 years of age, prescribed an oral antibiotic, and had ≥2 diagnoses of acne ≥7 days apart.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
